Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
Name | Medroxyprogesterone 400mg tablets |
BNF code | 0803020H0AAAFAF |
Virtual Therapeutic Moiety | Medroxyprogesterone |
Date identifier became valid | 26 May 2023 |
Previous product identifier | 327283000 |
Basis of preferred name | rINN - Recommended International Non-proprietary |
Prescribing status | Valid as a prescribable product |
Sugar free | ✗ |
Gluten free | ✗ |
Preservative free | ✗ |
CFC free | ✗ |
Dose form | Discrete |
Unit dose form size | 1.000 |
Unit dose form units | tablet |
Unit dose unit of measure | tablet |
Virtual Product Ingredient | |
---|---|
Ingredient | Medroxyprogesterone acetate |
Basis of pharmaceutical strength | Based on Ingredient Substance |
Strength value numerator | 400.000 |
Strength value numerator unit | mg |
Ontology Drug Form & Route | |
Form & Route | tablet.oral |
Dose Form | |
Formulation | Oral tablet |
Drug Route | |
Route | Oral |
Controlled Drug Prescribing Information | |
Controlled Drug category | No Controlled Drug Status |
Actual Medicinal Products | |
Provera 400mg tablets (Pfizer Ltd) | |
Virtual Medicinal Product Packs | |
Medroxyprogesterone 400mg tablets 30 tablet |
dm+d data retrieved from TRUD: release NHSBSA_11.1.0_20241111000001, imported on 12th November 2024 at 03:53:04.